Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/nipple-sparing mastectomy. (December 2022)

• Record Type: Journal Article
• Authors: Kim, Nalee; Park, Won; Cho, Won Kyung; Kim, Hae Young; Choi, Doo Ho; Nam, Seok Jin; Kim, Seok Won; Lee, Jeong Eon; Yu, Jonghan; Chae, Byung Joo; Lee, Se Kyung; Ryu, Jai Min; Mun, Goo-Hyun; Pyon, Jai-Kyong; Jeon, Byung-Joon
• Is Part Of: Breast. Volume 66(2022)
• Page Start: 54
• Page End: 61
• Publication Date: 2022-12
• Subjects: Breast cancer -- Mastectomy -- Skin-sparing mastectomy -- Nipple-sparing mastectomy -- Radiation therapy -- Local recurrence; Breast -- Diseases -- Periodicals; Breast -- Tumors -- Periodicals; Breast -- Periodicals; Electronic journals; Periodicals; 616
• DOI: 10.1016/j.breast.2022.09.004
• Languages: English
• ISSNs: 0960-9776

Abstract

Abstract: Aim: Both skin-sparing mastectomy (SSM) and nipple-sparing mastectomy (NSM) have been widely adopted. Although postmastectomy radiation therapy (PMRT) can improve clinical outcomes, it can worsen cosmesis following reconstruction. Therefore, identifying risk factors of ipsilateral breast tumor recurrence (IBTR) could help de-escalate PMRT after NSM/SSM in patients with pT1-2 disease. Methods: We retrospectively reviewed patients treated with SSM (N = 400) and NSM (N = 156) in patients with pT1-2N0-1 disease between 2009 and 2016. Seventy-four patients received PMRT with 50–50.4 Gy in 25–28 fractions. The Cox proportional hazards model was used to analyze the prognostic factors of IBTR. Results: With a median follow-up of 66.2 months, 17 IBTR events were observed, with 5-year IBTR-free rate of 97.2%. Although only one IBTR was observed after PMRT, there was no statistical difference in the 5-year IBTR-free rate (PMRT vs. no PMRT, 98.6% vs. 97.0%, p = 0.360). Multivariable analyses demonstrated that age ≤45 years and lymphovascular invasion (LVI) were adverse features of IBTR. The low-risk group (0 risk factor) showed a better 5-year IBTR-free rate than the high-risk group (≥1 risk factor) (100.0% vs. 95.8%, p = 0.003). In the high-risk group, PMRT slightly improved 5-year IBTR-free rate compared with no PMRT (98.6% vs. 95.2%, p = 0.166). In addition, PMRT increased 5-year cumulative incidence of reconstruction failure (10.0% vs. 2.8%, p = 0.001). Conclusion: We identified risk factors (age and LVI) related to IBTR following upfront SSM/NSM with pT1-2 disease. As a hypothesis-generating study, de-escalation of PMRT by omitting chest wall irradiation in selective patients could improve reconstruction-related complications without compromising oncologic outcomes. Highlights: IBTR-free rate at 5 years after SSM/NSM in pT1-2N0-1 disease was 97.2%. Age ≤45 years and tumor with LVI were associated with increased IBTR rate. Omitting chest wall RT to selective patients could improve reconstruction outcomes.